globalnews.ca
83%
480
AstraZeneca vaccine ‘still a win,’ needs better promotion by officials: experts
COVID-19 should be prioritized for immunization with the Oxford-AstraZeneca vaccine now that a national panel is not recommending it for seniors, two experts say.Caroline Colijn, a COVID-19 modeller and mathematician at Simon Fraser University, and Horacio Bach, an adjunct professor in the division of infectious diseases at the University of British Columbia, also say the Oxford-AstraZeneca vaccine could be better promoted by provincial health officials as a strong contender to the Pfizer-BioNTech and Moderna vaccines.The National Advisory Committee on Immunization has recommended that the Oxford-AstraZeneca not be used for people 65 and over due to concern about limited data on how it will work in older populations, even after Health